These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 21913913)

  • 1. Full-length visfatin levels are associated with inflammation in women with polycystic ovary syndrome.
    Lajunen TK; Purhonen AK; Haapea M; Ruokonen A; Puukka K; Hartikainen AL; Savolainen MJ; Morin-Papunen L; Tapanainen JS; Franks S; Järvelin MR; Herzig KH
    Eur J Clin Invest; 2012 Mar; 42(3):321-8. PubMed ID: 21913913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma visfatin level in women with polycystic ovary syndrome.
    Dıkmen E; Tarkun I; Cantürk Z; Cetınarslan B
    Gynecol Endocrinol; 2011 Jul; 27(7):475-9. PubMed ID: 20586547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between serum apelin, visfatin levels, and body composition in Polycystic Ovary Syndrome patients.
    Kuai D; Tang Q; Wang X; Yan Q; Tian W; Zhang H
    Eur J Obstet Gynecol Reprod Biol; 2024 Jun; 297():24-29. PubMed ID: 38555852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma visfatin levels in normal weight women with polycystic ovary syndrome.
    Panidis D; Farmakiotis D; Rousso D; Katsikis I; Delkos D; Piouka A; Gerou S; Diamanti-Kandarakis E
    Eur J Intern Med; 2008 Oct; 19(6):406-12. PubMed ID: 18848173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome.
    Kowalska I; Straczkowski M; Nikolajuk A; Adamska A; Karczewska-Kupczewska M; Otziomek E; Wolczynski S; Gorska M
    Hum Reprod; 2007 Jul; 22(7):1824-9. PubMed ID: 17582143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are plasma levels of visfatin and retinol-binding protein 4 (RBP4) associated with body mass, metabolic and hormonal disturbances in women with polycystic ovary syndrome?
    Olszanecka-Glinianowicz M; Madej P; Zdun D; Bożentowicz-Wikarek M; Sikora J; Chudek J; Skałba P
    Eur J Obstet Gynecol Reprod Biol; 2012 May; 162(1):55-61. PubMed ID: 22397743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum visfatin levels in women with polycystic ovary syndrome.
    Güdücü N; İşçi H; Görmüş U; Yiğiter AB; Dünder I
    Gynecol Endocrinol; 2012 Aug; 28(8):619-23. PubMed ID: 22313145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma visfatin level in lean women with PCOS: relation to proinflammatory markers and insulin resistance.
    Gen R; Akbay E; Muslu N; Sezer K; Cayan F
    Gynecol Endocrinol; 2009 Apr; 25(4):241-5. PubMed ID: 19408173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of metformin on serum visfatin levels in patients with polycystic ovary syndrome.
    Ozkaya M; Cakal E; Ustun Y; Engin-Ustun Y
    Fertil Steril; 2010 Feb; 93(3):880-4. PubMed ID: 19111298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between circulating visfatin/nicotinamide phosphoribosyltransferase, obesity, inflammation and lipids profile in elderly population, determined by structural equation modeling.
    Owczarek AJ; Olszanecka-Glinianowicz M; Kocełak P; Bożentowicz-Wikarek M; Brzozowska A; Mossakowska M; Puzianowska-Kuźnicka M; Grodzicki T; Więcek A; Chudek J
    Scand J Clin Lab Invest; 2016 Dec; 76(8):632-640. PubMed ID: 27712122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adipokines, insulin resistance and hyperandrogenemia in obese patients with polycystic ovary syndrome: cross-sectional correlations and the effects of weight loss.
    Spanos N; Tziomalos K; Macut D; Koiou E; Kandaraki EA; Delkos D; Tsourdi E; Panidis D
    Obes Facts; 2012; 5(4):495-504. PubMed ID: 22854419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum visfatin and adiponectin - markers in women with polycystic ovarian syndrome.
    Bannigida DM; Nayak SB; R V
    Arch Physiol Biochem; 2020 Oct; 126(4):283-286. PubMed ID: 30318936
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of insulin resistance and plasma levels for visfatin and resistin in obese and non-obese patients with polycystic ovary syndrome.
    Gul OO; Cander S; Gul B; Açıkgoz E; Sarandol E; Ersoy C
    Eur Cytokine Netw; 2015; 26(4):73-8. PubMed ID: 26967765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased visfatin messenger ribonucleic acid and protein levels in adipose tissue and adipocytes in women with polycystic ovary syndrome: parallel increase in plasma visfatin.
    Tan BK; Chen J; Digby JE; Keay SD; Kennedy CR; Randeva HS
    J Clin Endocrinol Metab; 2006 Dec; 91(12):5022-8. PubMed ID: 17003086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome.
    Kurek Eken M; Sahin Ersoy G; Yayla Abide C; Sanverdi İ; Devranoglu B; Kutlu T; Çevik Ö
    J Obstet Gynaecol; 2019 Oct; 39(7):975-980. PubMed ID: 31064233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visfatin and SREBP-1c mRNA Expressions and Serum Levels Among Egyptian Women with Polycystic Ovary Syndrome.
    Abdul-Maksoud RS; Zidan HE; Saleh HS; Amer SA
    Genet Test Mol Biomarkers; 2020 Jul; 24(7):409-419. PubMed ID: 32460545
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum visfatin is elevated in Chinese women with polycystic ovary syndrome, but might not be a reliable predictor of their glucose intolerance.
    Hong Y; Zhao XM; Huang LL; Li L; Chen XL; Yang DZ
    J Biol Regul Homeost Agents; 2012; 26(2):221-9. PubMed ID: 22824749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-visfatin levels in women with polycystic ovary syndrome: evidence from a meta-analysis.
    Sun Y; Wu Z; Wei L; Liu C; Zhu S; Tang S
    Gynecol Endocrinol; 2015 Oct; 31(10):808-14. PubMed ID: 26422683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for visfatin as an independent predictor of endothelial dysfunction in polycystic ovary syndrome.
    Pepene CE
    Clin Endocrinol (Oxf); 2012 Jan; 76(1):119-25. PubMed ID: 21740456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of Serum Visfatin Level in Non-obese Women with Polycystic Ovary Syndrome and Matched Control.
    Ali AI; Nori W
    Reprod Sci; 2022 Nov; 29(11):3285-3293. PubMed ID: 35687303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.